Christina A. Wilson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christina A. Wilson has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
David K. Stone
First Physicians Group of Sarasota Memorial Health Care System (DKS), Sarasota, Florida; and Department of Neurology (NB, CAW), University of Florida, Gainesville, Florida
2 shared publications- Koto Ishida
Department of Neurology, NYU Langone Health, New York, NY
2 shared publications Natalie Buchwald
Department of Neurology, University of Florida, Gainesville, FL, United States of America
2 shared publicationsAmita Singh
Department of Neurology, University of Florida, Gainesville, FL, United States of America
1 shared publicationB.P. Jackson
Department of Pathology, Thomas Jefferson University, Philadelphia, PA, USA
1 shared publicationBrett Cucchiara
From the University of Pennsylvania Medical Center, Philadelphia, Pa
1 shared publication
Latest Publications
- Open Access
- 18 February 2023
- Published by Elsevier in American Heart Journal Plus: Cardiology Research and Practice
- Vol. 27, 100277
Small-vessel disease in the brain
- 18 February 2023
- Published by Elsevier in American Heart Journal Plus: Cardiology Research and Practice
- Vol. 27, 100277
Open AccessSmall-vessel disease in the brain
- 28 January 2020
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 40 (1) , 60-66
Updates in the Management of Cryptogenic Stroke and Patent Foramen Ovale
Background: Stroke is a common neurological disorder and may present with visual symptoms. A thorough workup is warranted to determine the underlying cause of stroke to optimize secondary prevention. Despite a full workup, a high-risk mechanism may not be identified. Optimal treatment in this patient population has been the subject of recent research, particularly with regard to low-risk stroke mechanisms such as patent foramen ovale (PFO). Evidence acquisition: Using PubMed and published stroke guidelines, an evidence-based literature review was performed. Results: In this review, we compare cryptogenic stroke with the newer concept of embolic stroke of undetermined source, summarize the most common causes presumed to underlie these strokes, and review the evidence for optimal antithrombotic management. We also review recent clinical trials demonstrating a benefit for percutaneous closure of PFO for secondary stroke prevention in select patients. Conclusions: Stroke management is based on evaluation of individual patient-risk factors. Evaluation and treatment is ideally directed by a vascular neurologist to ensure optimal secondary prevention, especially in cases where an underlying etiology is not identified on initial workup.
- 28 January 2020
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 40 (1) , 60-66
Updates in the Management of Cryptogenic Stroke and Patent Foramen Ovale
Background: Stroke is a common neurological disorder and may present with visual symptoms. A thorough workup is warranted to determine the underlying cause of stroke to optimize secondary prevention. Despite a full workup, a high-risk mechanism may not be identified. Optimal treatment in this patient population has been the subject of recent research, particularly with regard to low-risk stroke mechanisms such as patent foramen ovale (PFO). Evidence acquisition: Using PubMed and published stroke guidelines, an evidence-based literature review was performed. Results: In this review, we compare cryptogenic stroke with the newer concept of embolic stroke of undetermined source, summarize the most common causes presumed to underlie these strokes, and review the evidence for optimal antithrombotic management. We also review recent clinical trials demonstrating a benefit for percutaneous closure of PFO for secondary stroke prevention in select patients. Conclusions: Stroke management is based on evaluation of individual patient-risk factors. Evaluation and treatment is ideally directed by a vascular neurologist to ensure optimal secondary prevention, especially in cases where an underlying etiology is not identified on initial workup.
- 23 October 2018
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 18 (12) , 98
Management of Blunt Cerebrovascular Injury
This review provides an updated summary of blunt cerebrovascular injury (BCVI) to guide clinicians in its early diagnosis and prevention and treatment of stroke associated with such injury.
- 23 October 2018
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 18 (12) , 98
Management of Blunt Cerebrovascular Injury
This review provides an updated summary of blunt cerebrovascular injury (BCVI) to guide clinicians in its early diagnosis and prevention and treatment of stroke associated with such injury.
- 1 May 2016
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 25 (5) , 1135-1140
Diagnostic Yield of Echocardiography in Transient Ischemic Attack
- 1 May 2016
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 25 (5) , 1135-1140
Diagnostic Yield of Echocardiography in Transient Ischemic Attack
- 2 June 2015
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 27 (1) , 31-37
Etiology of Corpus Callosum Lesions with Restricted Diffusion
Infarction of the corpus callosum is rare, and other conditions can cause magnetic resonance imaging (MRI) restricted diffusion in the callosum, leading to diagnostic uncertainty. We sought to characterize the etiology of lesions with diffusion restriction in the corpus callosum.
- 2 June 2015
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 27 (1) , 31-37
Etiology of Corpus Callosum Lesions with Restricted Diffusion
Infarction of the corpus callosum is rare, and other conditions can cause magnetic resonance imaging (MRI) restricted diffusion in the callosum, leading to diagnostic uncertainty. We sought to characterize the etiology of lesions with diffusion restriction in the corpus callosum.
- 1 March 2013
- Published by Wolters Kluwer Health in Stroke
- Vol. 44 (3) , 803-805
Convergent Validity and Interrater Reliability of Estimating the ABCD 2 Score From Medical Records
Background and Purpose—: The ABCD 2 score is increasingly used for risk stratification of transient ischemic attack patients. We sought to determine the reliability and convergent validity of retrospective ABCD 2 score estimation from medical records. Methods—: We compared ABCD 2 scores that were prospectively determined by a vascular neurology attending to scores determined retrospectively from medical record review. Emergency department records and neurology consult notes for patients with acute transient ischemic attack were abstracted with explicit ABCD 2 scoring redacted. Scores were estimated by 2 independent raters using these records. Estimated ABCD 2 component scores, total scores, and risk category were compared both between retrospective raters and with prospectively obtained scores. Reliability was assessed using unweighted κ statistics. Results—: Interrater reliability was substantial with 72% exact agreement in total score between retrospective raters (κ=0.64) and nearly perfect with 82% agreement for ABCD 2 category (κ=0.71). Interrater agreement was best for age and diabetes mellitus and poorest for clinical features and duration. Agreement between the retrospective raters and prospectively obtained score was >90% for age, blood pressure, and diabetes mellitus, but only ≈70% for clinical features and duration. Retrospectively, estimated total ABCD 2 score exactly matched the prospective score in 58% of patients for rater 1 and 44% of patients for rater 2. Retrospectively, estimated ABCD 2 category matched the prospectively scored category in 67% of patients for rater 1 and 71% of patients for rater 2. Conclusions—: The ABCD 2 score can be abstracted from medical records with substantial interrater reliability but limited convergent validity. This may lead to misclassification of risk category in more than one third of patients.
- 1 March 2013
- Published by Wolters Kluwer Health in Stroke
- Vol. 44 (3) , 803-805
Convergent Validity and Interrater Reliability of Estimating the ABCD 2 Score From Medical Records
Background and Purpose—: The ABCD 2 score is increasingly used for risk stratification of transient ischemic attack patients. We sought to determine the reliability and convergent validity of retrospective ABCD 2 score estimation from medical records. Methods—: We compared ABCD 2 scores that were prospectively determined by a vascular neurology attending to scores determined retrospectively from medical record review. Emergency department records and neurology consult notes for patients with acute transient ischemic attack were abstracted with explicit ABCD 2 scoring redacted. Scores were estimated by 2 independent raters using these records. Estimated ABCD 2 component scores, total scores, and risk category were compared both between retrospective raters and with prospectively obtained scores. Reliability was assessed using unweighted κ statistics. Results—: Interrater reliability was substantial with 72% exact agreement in total score between retrospective raters (κ=0.64) and nearly perfect with 82% agreement for ABCD 2 category (κ=0.71). Interrater agreement was best for age and diabetes mellitus and poorest for clinical features and duration. Agreement between the retrospective raters and prospectively obtained score was >90% for age, blood pressure, and diabetes mellitus, but only ≈70% for clinical features and duration. Retrospectively, estimated total ABCD 2 score exactly matched the prospective score in 58% of patients for rater 1 and 44% of patients for rater 2. Retrospectively, estimated ABCD 2 category matched the prospectively scored category in 67% of patients for rater 1 and 71% of patients for rater 2. Conclusions—: The ABCD 2 score can be abstracted from medical records with substantial interrater reliability but limited convergent validity. This may lead to misclassification of risk category in more than one third of patients.